Home › Head and Neck Squamous Cell Carcinoma › New Jersey › Newark
Head and Neck Squamous Cell Carcinoma clinical trials in Newark, NJ
5 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RecruitingPhase 2/3
- Site #0145, Newark
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RecruitingPhase 1
- ALX Center 12, Morristown · 17 mi away
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Rutgers New Jersey Medical School, Newark
- Cooperman Barnabas Medical Center, Livingston · 9 mi away
- Morristown Medical Center, Morristown · 17 mi away
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RecruitingPhase 2/3
- Saint Barnabas Medical Center, Livingston · 9 mi away
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- Summit Medical Group (site 205), Florham Park · 12 mi away
- Atlantic Health System, Morristown Medical Center (site 124), Morristown · 17 mi away
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Chicago, IL26 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- New Haven, CT22 studies
Other studies in Newark
- Breast Cancer18 studies
- Spinal Cord Injuries13 studies
- Non-Small Cell Lung Cancer13 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure10 studies
- Metastatic Cancer10 studies
- Cardiovascular Disease9 studies
- Pancreatic Cancer9 studies
- Melanoma8 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Crohn's Disease7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.